LEoPARD has been awarded an internal grant at maximum value — a full request of $2,000 — by the Vermont Biomedical Research Network (VBRN). Funds received from the grant application — entitled “Quantitative structure-activity relationship (QSAR) study of commercially-available capsaicin, capsaicinoids, capsinoids, and their biosynthetic intermediates: enzymatic and cellular approaches” — is added to a previous … Continue reading LEoPARD awarded internal grant from Vermont Biomedical Research Network
LEoPARD awarded startup supplement funds from Vermont Biomedical Research Network
LEoPARD has been awarded a startup supplement grant at maximum value -- a full request of $10,000 -- by the Vermont Biomedical Research Network (VBRN). Funds received from the grant application -- entitled “Characterizing capsaicinoid and capsinoid mechanisms of insulin sensitization” -- will be added to a startup package already committed by Saint Michael's College. … Continue reading LEoPARD awarded startup supplement funds from Vermont Biomedical Research Network
LEoPARD begins one-month countdown to major fundraising push for SuRe-BET
During the first week of April 2021 -- LEoPARD will be holding two fundraising events to support undergraduate student research in biochemistry at Colorado Mesa University, primarily for our Summer Research towards Biochemical Evaluation of Therapeutics (or SuRe-BET) initiative! Firkin fundraiser at Kannah Creek Brewing Company On Monday, April 5th, LEoPARD will be the beneficiary … Continue reading LEoPARD begins one-month countdown to major fundraising push for SuRe-BET
Laboratory for Evaluation of Pharmacological Agents in Remediation of Disease (LEoPARD) 